Skip to Content

N899 300 (Nizatidine 300 mg)

Pill with imprint N899 300 is Beige, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for N899 300

Nizatidine

Imprint:
N899 300
Strength:
300 mg
Color:
Beige
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide